DALLY 发表于 2025-3-25 05:28:13

Submitted on: 15 November 2007.
Revised on: 22 January 2008.
Accepted on: 25 February 2008.

___________________Clinical Pharmacology-Advances and Applications

油膏 发表于 2025-3-25 08:30:30

http://reply.papertrans.cn/1/58/5715/5715-22.png

启发 发表于 2025-3-25 14:43:34

Submitted on: 21 August 2020.
Revised on: 08 October 2020.
Accepted on: 05 November 2020.

___________________Clinical Pharmacology-Advances and Applications

禁令 发表于 2025-3-25 18:16:26

http://reply.papertrans.cn/1/58/5715/5715-24.png

JECT 发表于 2025-3-25 20:51:31

http://reply.papertrans.cn/1/58/5715/5715-25.png

悬挂 发表于 2025-3-26 01:12:04

Submitted on: 23 August 1998.
Revised on: 11 October 1998.
Accepted on: 24 October 1998.

___________________Clinical Pharmacology-Advances and Applications

MUTED 发表于 2025-3-26 06:10:53

http://reply.papertrans.cn/1/58/5715/5715-27.png

dissent 发表于 2025-3-26 12:24:16

Submitted on: 22 March 2003.
Revised on: 20 April 2003.
Accepted on: 04 June 2003.

___________________Clinical Pharmacology-Advances and Applications

不知疲倦 发表于 2025-3-26 15:36:09

http://reply.papertrans.cn/1/58/5715/5715-29.png

Landlocked 发表于 2025-3-26 17:28:01

http://reply.papertrans.cn/1/58/5715/5715-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Clinical Pharmacology-Advances and Applications 2024/2025影响因子:3.192 (CLIN PHARMACOL-ADV A) (1179-1438). (PHARMACO